Case Study 01
Strategic Regulatory Advice, Health Authority Interactions and Submission Management
Case Study 04
01
03
The client is a small US-based company that has been granted SME status. The company wishes to file an Orphan Designation in Europe and benefit from the SME incentives offered for this process. They require strategic EU regulatory support, publishing assistance, and help setting up EU submission portals.
02
03
What the client asked for

File an Orphan Designation in Europe
File and benefit from the SME incentives

Provide strategic EU advice
Provide publishing assistance
Provide support in setting up EU submission portals
03
03
How we supported the client
Provided guidance on the benefits and incentives of SME status in the EU for the orphan designation application process

Offered strategic oversight and guidance on the EU orphan designation application process and best practices for navigating the submission process


Assisted in the submission of the Orphan Designation including publishing through our partner network


Assisted in preparing and submitting the application through the appropriate EU portals, including IRIS (a secure online platform for handling product-related scientific and regulatory procedures with the European Medicines Agency (EMA))

Strategically laid out options when and where to go for scientific advice in Europe by weighting national versus central advice based on client`s needs and planned development program

Wrote the scientific advice package
/ orphan designation as well as reviewed


Advised on opportunities of acceleration options in Europe

Submitted a request for a SME
(micro, small and medium-sized enterprises)


Strategic 
Regulatory
Advice
Interactions with Health Authorities
Submission
Management
Partnering with industry experts
Client quote
Our partners at Therainnova have been an integral part of our global development team, providing critical EU regulatory insights that have added significant clarity and validation of our overall clinical development strategy
Theresa Matkovits, Ph.D.
Chief Development Officer, Matinas Biopharma
© therainnova 2023
Follow
Terms and ConditionsPrivacy Policy
Design by: G Design Studio
Code: codr.run
Terms and Conditions
Privacy Policy
Design by: G Design Studio
Code: codr.run
© therainnova 2023